TrialScientific reports2017

Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: a randomized controlled trial.

Siming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.